Longboard pharmaceuticals to present at the cantor virtual global healthcare conference on september 28, 2021

San diego, sept. 21, 2021 (globe newswire) -- longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its senior leadership team will present in a fireside chat format at the cantor virtual global healthcare conference on september 28, 2021.
LBPH Ratings Summary
LBPH Quant Ranking